Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study

CONCLUSIONS: Fimasartan-based BP lowering achieved the target BP in two-thirds of patients at 24 weeks, and was generally well tolerated.PMID:34184441 | PMC:PMC8242309 | DOI:10.3988/jcn.2021.17.3.344
Source: Journal of Clinical Neurology - Category: Neurology Authors: Source Type: research